Neuroprotective effects of neuropeptide Y against neurodegenerative disease - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Current Neuropharmacology Année : 2021

Neuroprotective effects of neuropeptide Y against neurodegenerative disease

Résumé

Neuropeptide Y (NPY), a 36 amino acid peptide, is widely expressed in the mammalian brain. Changes in NPY levels in different brain regions and plasma have been described in several neurodegenerative diseases, including Alzheimer’s disease, Parkinson's disease, Huntington’s disease, Amyotrophic Lateral Sclerosis, and Machado-Joseph disease. The changes in NPY levels may reflect the attempt to set up an endogenous neuroprotective mechanism to counteract the degenerative process. Accumulating evidence indicates that NPY can function as an anti- apoptotic, anti-inflammatory, and pro-phagocytic agent, which may be used effectively to halt or to slow down the progression of the disease. In this review, we will focus on the neuroprotective roles of NPY in several neuropathological conditions, with a particular focus on the anti- inflammatory properties of NPY.

Domaines

Neurobiologie

Dates et versions

hal-03361423 , version 1 (01-10-2021)

Identifiants

Citer

Stéphanie Pain, Sébastien Brot, Afsaneh Gaillard. Neuroprotective effects of neuropeptide Y against neurodegenerative disease. Current Neuropharmacology, 2021, 19, ⟨10.2174/1570159X19666210906120302⟩. ⟨hal-03361423⟩

Collections

UNIV-POITIERS LNEC
16 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More